Suchen
DaVita Inc
DVAZur Watchlist hinzufügen
198.650USD
+2.390+1.22%
Handelsschluss 05/08, 16:00（ET）Kurse um 15 Minuten verzögert
12.75BMarktkapitalisierung
18.16KGV TTM
mehr Informationen über DaVita Inc Unternehmen
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
DaVita Inc Informationen
BörsenkürzelDVA
Name des UnternehmensDaVita Inc
IPO-datumOct 31, 1995
CEORodriguez (Javier J)
Anzahl der mitarbeiter76000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse2000 16th St
StadtDENVER
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl80202-5117
Telefon13105362668
Websitehttps://www.davita.com/
BörsenkürzelDVA
IPO-datumOct 31, 1995
CEORodriguez (Javier J)
Führungskräfte von DaVita Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
845.14K
+1.48%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
161.55K
+33.27%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
106.29K
+35.70%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
47.08K
+72.21%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
31.27K
+53.52%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.70K
+1.24%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
14.31K
+2.32%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.77K
+2.41%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.56K
+4.39%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
845.14K
+1.48%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
161.55K
+33.27%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
106.29K
+35.70%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
47.08K
+72.21%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
31.27K
+53.52%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.70K
+1.24%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
6.74B
49.41%
Patient service - Commercial
4.19B
30.73%
Patient service - Other government
1.26B
9.27%
Patient service - Medicaid and Managed Medicaid
871.70M
6.39%
Other - Medicare and Medicare Advantage
507.61M
3.72%
Andere
67.31M
0.49%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
6.74B
49.41%
Patient service - Commercial
4.19B
30.73%
Patient service - Other government
1.26B
9.27%
Patient service - Medicaid and Managed Medicaid
871.70M
6.39%
Other - Medicare and Medicare Advantage
507.61M
3.72%
Andere
67.31M
0.49%
Aktionärsstatistik
Aktualisiert: Fri, May 8
Aktualisiert: Fri, May 8
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
3.42%
Weschler (R Ted)
3.40%
Invesco Capital Management LLC
2.36%
Andere
39.55%
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.98%
The Vanguard Group, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
3.42%
Weschler (R Ted)
3.40%
Invesco Capital Management LLC
2.36%
Andere
39.55%
Aktionärstypen
Aktionäre
Anteil
Holding Company
44.99%
Investment Advisor
25.97%
Investment Advisor/Hedge Fund
15.50%
Hedge Fund
8.35%
Individual Investor
5.70%
Research Firm
3.59%
Pension Fund
1.21%
Sovereign Wealth Fund
0.67%
Bank and Trust
0.65%
Institutionelle Beteiligung
Aktualisiert: Sun, Apr 5
Aktualisiert: Sun, Apr 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
1310
36.02M
56.10%
-3.26M
2025Q4
1268
36.29M
57.41%
+15.99K
2025Q3
1299
36.28M
57.59%
-1.47M
2025Q2
1288
37.75M
54.27%
+725.11K
2025Q1
1275
37.24M
54.43%
-4.83M
2024Q4
1234
39.31M
53.45%
-1.10M
2024Q3
1192
40.91M
54.63%
-1.68M
2024Q2
1162
42.62M
55.55%
-1.85M
2024Q1
1146
44.41M
55.70%
-4.44M
2023Q4
1143
45.66M
55.03%
+259.36K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Berkshire Hathaway Inc.
30.10M
43.91%
-1.66M
-5.22%
Jan 29, 2026
The Vanguard Group, Inc.
4.14M
6.2%
-64.89K
-1.54%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.19M
3.28%
-202.51K
-8.45%
Dec 31, 2025
Weschler (R Ted)
2.18M
3.27%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.51M
2.27%
+114.35K
+8.17%
Dec 31, 2025
State Street Investment Management (US)
1.44M
2.15%
-396.34K
-21.60%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
1.19M
1.78%
+636.19K
+114.88%
Dec 31, 2025
Gates Capital Management, Inc.
1.18M
1.76%
-14.90K
-1.25%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.09M
1.63%
+3.51K
+0.32%
Dec 31, 2025
Geode Capital Management, L.L.C.
978.79K
1.47%
-44.58K
-4.36%
Dec 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Aztlan Global Stock Selection DM SMID ETF
2.59%
State Street SPDR S&P Health Care Services ETF
1.84%
Strategas Global Policy Opportunities ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.47%
Pacer US Cash Cows Growth ETF
1.02%
AdvisorShares Insider Advantage ETF
0.95%
Global X Aging Population ETF
0.75%
iShares U.S. Healthcare Providers ETF
0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.67%
LeaderShares AlphaFactor US Core ETF
0.66%
Mehr Anzeigen
Aztlan Global Stock Selection DM SMID ETF
Anteil2.59%
State Street SPDR S&P Health Care Services ETF
Anteil1.84%
Strategas Global Policy Opportunities ETF
Anteil1.64%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.47%
Pacer US Cash Cows Growth ETF
Anteil1.02%
AdvisorShares Insider Advantage ETF
Anteil0.95%
Global X Aging Population ETF
Anteil0.75%
iShares U.S. Healthcare Providers ETF
Anteil0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Anteil0.67%
LeaderShares AlphaFactor US Core ETF
Anteil0.66%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
